Status and phase
Conditions
Treatments
About
Study to assess the effect of JMKX001899 on QTc interval in healthy volunteers
Full description
A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study to Evaluate the Pharmacokinetics and the Effect on Cardiac Repolarization of JMKX001899 Administered as a Tablet Formulation Under Fed Conditions in Healthy Subjects
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
27 participants in 3 patient groups
Loading...
Central trial contact
WEIXIA LI
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal